Power, Disputes, and Geopolitics in the Pharmaceutical Sector

The pharmaceutical sector achieved global revenues of USD 1.6 trillion in 2023, underscoring its immense economic power and strategic influence on the modern economy and global politics. This article, grounded in extensive data collection, systematization, and analysis, explores the dynamics of this power and influence. It examines the economic and political value of companies in the sector, the conflicts between corporations and nations, the geopolitical role of the sector during the COVID-19 pandemic, and its capacity to shape domestic policies through intensive lobbying, financial contributions to lawmakers, and interactions with regulatory and oversight bodies.